[go: up one dir, main page]

EA200700878A1 - Лечение или предупреждение геморрагических вирусных инфекций с помощью иммуномодулирующих соединений - Google Patents

Лечение или предупреждение геморрагических вирусных инфекций с помощью иммуномодулирующих соединений

Info

Publication number
EA200700878A1
EA200700878A1 EA200700878A EA200700878A EA200700878A1 EA 200700878 A1 EA200700878 A1 EA 200700878A1 EA 200700878 A EA200700878 A EA 200700878A EA 200700878 A EA200700878 A EA 200700878A EA 200700878 A1 EA200700878 A1 EA 200700878A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
prevention
viral infections
hemorrhagic viral
immunomodulating compounds
Prior art date
Application number
EA200700878A
Other languages
English (en)
Other versions
EA012342B1 (ru
Inventor
Эрик С. Моссел
Синтия У. Татхилл
Алфред Р. Рудолф
Кларенс Джеймс Питерс
Original Assignee
Сциклон Фармасьютикалс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сциклон Фармасьютикалс, Инк. filed Critical Сциклон Фармасьютикалс, Инк.
Publication of EA200700878A1 publication Critical patent/EA200700878A1/ru
Publication of EA012342B1 publication Critical patent/EA012342B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

В заявке описан способ лечения, заключающийся в том, что пациенту, страдающему геморрагической вирусной инфекцией или имеющему риск ее приобретения, вводят иммуномодулирующее соединение.
EA200700878A 2004-10-27 2005-10-27 Лечение или предупреждение геморрагических вирусных инфекций с помощью иммуномодулирующих соединений EA012342B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62202204P 2004-10-27 2004-10-27
PCT/US2005/038834 WO2006047702A2 (en) 2004-10-27 2005-10-27 Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds

Publications (2)

Publication Number Publication Date
EA200700878A1 true EA200700878A1 (ru) 2007-10-26
EA012342B1 EA012342B1 (ru) 2009-10-30

Family

ID=36228480

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200700878A EA012342B1 (ru) 2004-10-27 2005-10-27 Лечение или предупреждение геморрагических вирусных инфекций с помощью иммуномодулирующих соединений

Country Status (19)

Country Link
US (1) US8193152B2 (ru)
EP (1) EP1814566B1 (ru)
JP (1) JP4874985B2 (ru)
KR (1) KR20070070202A (ru)
CN (1) CN101048171B (ru)
AT (1) ATE475426T1 (ru)
AU (1) AU2005299609A1 (ru)
BR (1) BRPI0517401A (ru)
CA (1) CA2585457A1 (ru)
DE (1) DE602005022612D1 (ru)
EA (1) EA012342B1 (ru)
ES (1) ES2350087T3 (ru)
IL (1) IL182710A (ru)
MX (1) MX2007005092A (ru)
NO (1) NO20072498L (ru)
NZ (1) NZ555322A (ru)
SG (1) SG163601A1 (ru)
UA (1) UA92727C2 (ru)
WO (1) WO2006047702A2 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006116053A1 (en) * 2005-04-22 2006-11-02 Sciclone Pharmaceuticals, Inc. Immunomodulator compounds as vaccine enhancers
CA2677749A1 (en) 2007-02-13 2008-08-21 Sciclone Pharmaceuticals, Inc. Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa
WO2012109106A1 (en) * 2011-02-09 2012-08-16 Sciclone Pharmaceuticals, Inc. Thymosin alpha peptide for preventing, reducing the severity of, and treating infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916878A (en) * 1995-11-28 1999-06-29 Edward T. Wei γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith
US5744452A (en) * 1995-11-28 1998-04-28 Edward T. Wei γ-L-glutamyl containing immunomodulator compounds and methods therewith
JP2007537280A (ja) 2004-05-14 2007-12-20 サイクローン・ファーマシューティカルズ・インコーポレイテッド 免疫調節性化合物を用いる呼吸器のウイルス感染の治療又は予防
UA12948U (en) 2005-07-11 2006-03-15 Inst Of Veterinary Medicine Uk Associated inactivated concentrated serdosan vaccine against colibacteriosis, edematous disease, pasteurellosis, salmonellosis, and anaerobic enterotoxicemia of pigs

Also Published As

Publication number Publication date
WO2006047702A2 (en) 2006-05-04
CA2585457A1 (en) 2006-05-04
WO2006047702A3 (en) 2006-07-20
NZ555322A (en) 2009-02-28
EP1814566B1 (en) 2010-07-28
ATE475426T1 (de) 2010-08-15
JP4874985B2 (ja) 2012-02-15
IL182710A0 (en) 2007-07-24
EP1814566A4 (en) 2008-05-07
DE602005022612D1 (de) 2010-09-09
SG163601A1 (en) 2010-08-30
JP2008518031A (ja) 2008-05-29
NO20072498L (no) 2007-05-15
BRPI0517401A (pt) 2008-10-14
US20090143313A1 (en) 2009-06-04
UA92727C2 (ru) 2010-12-10
CN101048171A (zh) 2007-10-03
EP1814566A2 (en) 2007-08-08
ES2350087T3 (es) 2011-01-18
AU2005299609A1 (en) 2006-05-04
MX2007005092A (es) 2007-07-04
KR20070070202A (ko) 2007-07-03
EA012342B1 (ru) 2009-10-30
IL182710A (en) 2012-04-30
US8193152B2 (en) 2012-06-05
CN101048171B (zh) 2011-02-09

Similar Documents

Publication Publication Date Title
DE60327438D1 (de) Amino-substituierte cyclohexan derivate zur behandlung bakterieller infektionen
NO20052580D0 (no) Blandinger for behandling av infeksjon av Flavivirida viruser
TW200618810A (en) Treatment of respiratory syncytial virus (RSV) infection
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
NO20070988L (no) Vaksine for forebygging og behandling av HIV-infeksjon
EA200900802A1 (ru) Способы и композиции для лечения амилоидных заболеваний
EA200600078A1 (ru) Способы и композиции для лечения амилоидных заболеваний
DK1656372T3 (da) 2,4-pyrimidindiaminforbindelser til anvendelse til behandling eller forebyggelse af autoimmunsygdomme
EP1594512A4 (en) COMPOUNDS FOR THE TREATMENT OF VIRUS INFECTIONS
TW200733953A (en) Materials and methods for treating viral infections
AU2003291885A1 (en) Compounds and methods for the treatment or prevention of flavivirus infections
NO20052362D0 (no) Fremgangsmater for administrering av dalbavancin for behandling av bakterielle infeksjoner
EA200970529A1 (ru) Антивирусная композиция и способ ее применения
EA200601837A1 (ru) Бензоксазины для лечения заболеваний дыхательных путей
WO2007076091A3 (en) Treatment of viral infections using a tissue factor inhibitor
CY1110027T1 (el) Συνδυασμος ενωσεων πυριμιδυλαμινοβενζαμιδης και ιματινιβης για τη θεραπεια ή την προληψη των νεοπλασματικων ασθενειων
NO20043445L (no) Kombinasjonsterapi for behandling av bakterielle infeksjoner
NO20053348D0 (no) Farmasoytisk sammensetning for behandling av virusangrep.
EA200700878A1 (ru) Лечение или предупреждение геморрагических вирусных инфекций с помощью иммуномодулирующих соединений
DE602005007485D1 (de) Medikament zur behandlung von pilzinfektionen; insbesondere aspergillose
SG169362A1 (en) Treatment or prevention of respiratory viral infections with immunomodulator compounds
EA200870263A1 (ru) Внутривенный способ лечения вирусной инфекции
NO20054034D0 (no) Fremgangsmate for behandling av hypotyroidisme.
EP1484066A4 (en) Remedy for infections
WO2007046966A3 (en) Methods for the treatment of influenza

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU